HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Electronics Business			9.09B	9.98B	11.47B	11.05B	12.76B
Electronics Business Growth			-8.93%	-12.99%	3.84%	-13.45%	-13.25%
Cold Chain Business			43.50B	14.01B	32.08B	31.80B	45.74B
Cold Chain Business Growth			210.55%	-56.33%	0.87%	-30.48%	61.78%
Headquarters and Bio Business			384.33M	200.81M	189.68M	228.18M	684.71M
Headquarters and Bio Business Growth			91.40%	5.87%	-16.87%	-66.67%	-19.81%
Medical Device Business			-	25.48B	-	-	-
Inter-Segment Revenue			-384.33M	-1.54B	-152.71M	-146.15M	-222.78M
Total			52.59B	48.13B	43.59B	42.93B	58.97B
Total Growth			9.26%	10.43%	1.53%	-27.20%	35.29%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Korea			50.98B	46.82B	41.97B	41.16B	56.45B
Korea Growth			8.86%	11.56%	1.97%	-27.08%	38.29%
Japan			1.62B	1.31B	1.58B	1.64B	1.65B
Japan Growth			23.51%	-17.06%	-4.09%	-0.31%	-16.35%
United States of America			-	-	36.97M	109.38M	615.91M
United States of America Growth			-	-	-66.20%	-82.24%	-22.53%
People's Republic of China			-	-	-	14.18M	255.54M
People's Republic of China Growth			-	-	-	-94.45%	-
Total			52.59B	48.13B	43.59B	42.93B	58.97B
Total Growth			9.26%	10.43%	1.53%	-27.20%	35.29%

Source: S&P Global Market Intelligence.